| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |